
News|Articles|August 19, 2011
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
Advertisement
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Cancer survival fell and deaths rose during first two years of COVID-19
3
PBM reform. It has finally happened
4
TrumpRx launches; some experts question its long-term value
5

























